Navigation Links
CuraGen Presents Update on Clinical Development Program for,Belinostat

ng).

The Phase II portion of this trial for ovarian cancer has been initiated with 16 patients having been treated with 13 patients continuing on study and undergoing assessment to determine response to treatment. This trial utilizes a Simon Two Stage Design and is initially enrolling up to 18 patients. Two of the ongoing patients have achieved an objective response and upon confirmation the Company expects to expand the trial and enroll up to 32 patients to further define the objective response rate and tolerability of belinostat in combination with carboplatin and paclitaxel.

Furthermore, this Phase II study has been broadened to include an additional arm that will enroll up to 15 patients with transitional cell cancer of the bladder in order to evaluate the activity of belinostat in combination with carboplatin and paclitaxel in this patient population. Interim results are anticipated during the first half of 2008.

NCI P7267: Phase II trial evaluating intravenous belinostat monotherapy for micropapillary/borderline low malignant potential (LMP) ovarian carcinoma or advanced platinum resistant ovarian tumors

The Phase II trial is an open-label study evaluating belinostat as a single agent treatment for patients with either micropapillary/borderline LMP ovarian carcinoma or advanced platinum resistant ovarian tumors. The primary endpoint for the study is determination of objective response, as evaluated by RECIST and GCIG CA125 criteria. Secondary endpoints include evaluation of safety and tolerability of belinostat, stable disease rates, duration of response, progression-free survival, as well as median and overall survival. Enrollment of patients is ongoing into both arms of the trial. An objective clinical response has been recently observed in the LMP arm and is pending confirmation and review. This study is being sponsored by the National Cancer Institute (NCI) under a Clinical Trials Agreement with CuraGen, and being conducted unde
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
2. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
(Date:11/19/2009)...lif., Nov. 19 Alexza Pha...y that its corporate presentation will be webcast ...are Conference on Wednesday, December 2, 2009 at 9...ebcast from The New York Palace Hotel in New York ...esident and CEO. ,, To access the live presen...
(Date:11/19/2009)... 19 As the seasons change, another...s more on preparing yourself. ,, Listen to this...Inc. at: ,, http://inr.mediaseed.tv/oneClip_...Medialink is a division of The NewsMarket. Regist...aphics and photos at http://www.thenewsmarket.co...
(Date:11/19/2009)..., Nov. 19 Impliant, Inc., a develo...ional spinal fusion surgery, announced today that ...t team as the Vice President of Clinical and Regul...m.com/cgi-bin/prnh/20080527/NETU060LOGO ) ,, ...ry experience in the spinal and medical device fie...
Breaking Medicine Technology:Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3BioMarin to Present at the Baird Healthcare Conference 13799 1BioMarin to Present at the Baird Healthcare Conference 13799 2Video 3A FDA States Consumers Should Continue to Use alli 55996 1Video 3A FDA States Consumers Should Continue to Use alli 55996 2Accumetrics Inc Forms Partnership With Grifols as Its Distributor in Spain Portugal and Chile 55991 1Accumetrics Inc Forms Partnership With Grifols as Its Distributor in Spain Portugal and Chile 55991 2Accumetrics Inc Forms Partnership With Grifols as Its Distributor in Spain Portugal and Chile 55991 3
(Date:11/20/2009).... 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceutic...f Shareholders will be held on Monday, December 21...approval of two special resolutions. The first spe...le of all or substantially all of the assets of NU...the asset purchase agreement dated November 10, 20...
(Date:11/20/2009)... 20 Following a recall by Unilever...rom sale Shedd,s Country Crock ® Side Dishes ...rock ® Side Dishes DELUXE Four Cheese Pasta d...ollowing code dates and UPCs are affected: ,, ...eddar Broccoli Rice 21 oz, UPC 027400218316, Best ...
(Date:11/20/2009)...RNewswire-USNewswire/ -- The American Dental Assoc...ministration (FDA) to establish appropriate classi...ting concern about the safety of whitening product...of professional consultation or examination by a d...of chemically based tooth whitening or bleaching a...
(Date:11/20/2009)..., Nov. 20 Samuel Gladdi...ne what it means to be "happy" during the holidays...ialty in family counseling and chair of the Depart...ding says research shows that it is the pressure t...pression during the holidays. ,, That,s why he,...
(Date:11/20/2009)...e November 20 in the Journal of the National Canc...hopes that often appear in news coverage of cancer...h the media and journals to help alleviate the pro... Woloshin, M.D., M.S., of Center for Medicine and ...licy and Clinical Practice in New Hampshire, and B...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...ity Psychology Professor Tony Ro has published its...known as synesthesia, in which stimulation of one ...periences in a second sensory pathway. , Ro,s pap...e journal is available online via Wiley InterScien...
...archers at the Centre for Addiction and Mental Hea... consumption and the risk of head and neck cancers...icantly reduce their cancer risk. , According to... cancer of the esophagus, larynx and oral cavity. ...
...overy Projects, REDWOOD CITY, Calif., Sept. 26 G...ced today that it has obtained,commitments from se...ately,12.9 million shares of its common stock and ... to purchase the,shares and warrants for $1.84 per...
...form of care, experts say , WEDNESDAY, Sept. 26 (...sued new "performance measures" meant to boost pat.... , They say too many heart attack patients aren,t...can Association of Cardiovascular and Pulmonary Re...
...mmer traditionally,marks the return to school and ...liday baking seasons. This year, in response to re... obesity -- healthier cooking is a growing,trend. ...parents are responsible for maintaining their chil...
...mer,President of Ronco Inventions, Inc., has signe...and implement a new international direct sales and...C Bulletin Board: NNTN).,During his tenure as Pres...ion remarked, "Tim Dupler has a,proven track recor...
Other Medicine News:Health News:Research at Rice may help explain aspects of synesthesia 2Health News:Research at Rice may help explain aspects of synesthesia 3Health News:Alcohol and cancer: is drinking the new smoking? 2Health News:Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing 2Health News:Heart Attack Survivors Benefit From Rehab 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 3Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 4Health News:Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition 2
Lowman Bone Clamp
Reduction Forceps with Points
Bone Hooks
Kleinert-Kutz Bone-Cutting Rongeur
Medicine Products: